Company spokeswoman Michele Meixell clarified that the decision was made voluntarily, according to standard procedures, and added that the circumstances would now be assessed by an independent commission.
–
A clinical study of the coronavirus vaccine developed by AstraZeneca and Oxford University is being conducted in several locations. Health complications occurred in a participant in the United Kingdom. It is not clear what the problems are, or when they have manifested themselves. However, according to Stat News, a study participant suspected of having a “serious adverse reaction” is expected to recover.
–
Stat News said the suspension of clinical trials had an impact on other AstraZeneca trials and clinical trials conducted by other pharmaceutical companies. AstraZeneca said in a statement that “large studies may manifest the disease purely by chance, but the circumstances need to be reviewed independently”.
–
The company’s shares fell more than eight percent after the report was published, while its competitors in the development of the vaccine recorded growth. American Moderna attributed four percent, Pfizer less than one percent.
–
Nine American and European vaccine developers pledged on Tuesday to adhere to scientific safety standards for their experimental vaccines. The statement was issued due to growing concerns that safety standards would not be fully met in vaccine studies due to political pressure to bring the vaccine to market quickly.
—
![[Podcast] Preview 2020 – Kansas City Chiefs | Touchdown Actu (NFL Actu)](https://www.touchdownactu.com/wp-content/uploads/2020/08/travis-kelce-210820-1-1000x600.jpg "[Podcast] Preview 2020 – Kansas City Chiefs | Touchdown Actu (NFL Actu)")